🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 02155H101 (prev. 42224H104 )
- Market Cap
- Small Cap
- Previous Symbol
- PIP (changed 5/5/2017)
- Previous Name
- Pharmathene, Inc.
Business: Altimmune, Inc. is a clinical stage immunotherapeutics biotechnology company located in Montgomery County, MD with an additional operating site in London, UK. By leveraging the complementary attributes of its two innovative vaccine delivery platforms, RespirVec and Densigen, Altimmune is able to design and develop immunotherapeutic products tailored to address a wide range of disease indications including acute respiratory infections, chronic viral infections and cancer, with the potential for fundamental advantages over competing products.
Notes: May 4, 2017 -- PharmAthene, Inc. (NYSE MKT: PIP) and Altimmune, Inc. have completed a merger today. Following the merger, PharmAthene, Inc. will have a corporate name, Altimmune, Inc., and CUSIP change, 02155H101, undergo a 1 for 10 reverse stock split, and will begin trading on Nasdaq under the ticker symbol ALT. PharmAthene, Inc. will continue to be traded on NYSE MKT through the close of business on Thursday, May 4, 2017.
Company Contact
- CEO
- Vipin K. Garg
- CFO
- Greg Weaver
- Headquarters
- 910 Clopper Road Suite 201S, Gaithersburg, MD 20878
- Phone
- 240-654-1450
- Fax
- 410-269-2601
- Investor Relations
- Stacey Jurchison · 240-654-1450 · sjurchison@altimmune.com